CAS 1616703-93-5

2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate

CAS: 1616703-93-5

2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate

Purity: 95%

Molecular weight: 564.6g/mol

Ref: 54-PC110140

Ticagrelor EP Impurity C

CAS: 1616703-93-5

Formula: C₂₅H₃₀F₂N₆O₅S

Color and Shape: White To Off-White Solid

Molecular weight: 564.62

Ref: 4Z-T-817

Ticagrelor EP Impurity C

CAS: 1616703-93-5

Formula: C₂₅H₃₀F₂N₆O₅S

Molecular weight: 564.61

Ref: ST-EA-CP-T21003

2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate

CAS: 1616703-93-5

Purity: 95%

Molecular weight: 564.6099854

Ref: 10-F600691

Ticagrelor Acetate

Controlled Product

CAS: 1616703-93-5

Applications Ticagrelor Acetoxide is an acetoxy impurity of Ticagrelor (T437700). Ticagrelor (T437700), the first reversible oral P2Y12 receptor antagonist, provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).
References Matetzky, S., et al.: Circulation, 109, 3171 (2004), Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007), Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007)

Formula: C₂₅H₃₀F₂N₆O₅S

Color and Shape: White To Off-White

Molecular weight: 564.6

Ref: TR-D232265

Ticagrelor acetate

CAS: 1616703-93-5

Ticagrelor is a drug that is used for the prevention of stroke and death in people who have had a recent heart attack. The active ingredient in this drug is ticagrelor acetate, which is an impurity standard. Ticagrelor acetate selectively binds to the P2Y12 receptor on platelets and blocks the ADP-induced activation of the receptor, preventing platelet aggregation. This chemical has been shown to reduce thrombus formation and improve survival rates after a heart attack. TICAGRELOR ACETATE: Ticagrelor is a drug that is used for the prevention of stroke and death in people who have had a recent heart attack. The active ingredient in this drug is ticagrelor acetate, which is an impurity standard. Ticagrelor acetate selectively binds to the P2Y12 receptor on platelets and blocks the ADP-induced activation of the receptor,

Formula: C₂₅H₃₀F₂N₆O₅S

Purity: Min. 95%

Molecular weight: 564.6 g/mol

Ref: 3D-RPC70393